lunedì, 14 settembre 2026

Notizie AIOM – anno XVI n. 678

FDA Grants Larotrectinib Priority Review for NTRK+ Cancers

May 29, 2018 - The FDA has granted a priority review to a new drug application (NDA) for larotrectinib for the treatment of adult and pediatric patients with locally advanced or metastatic solid tumors with an NTRK gene fusion, according to Bayer and Loxo Oncology, the codevelopers ...
Leggi tutto

FDA Statement on the Signing of the Right to Try Act

May 30, 2018 - U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, released the following statement today: For patients with serious or immediately life-threatening diseases, the FDA remains committed to enhancing access to promising investigational ...
Leggi tutto

FDA Grants Orphan Drug Designation to Galinpepimut-S for Treatment of Multiple Myeloma

May 30, 2018 - The U.S. Food and Drug Administration (FDA) recently granted Orphan Drug designation to galinpepimut-S for the treatment of multiple myeloma. The drug is licensed from Memorial Sloan Kettering Cancer Center and targets the Wilms tumor 1 (WT1) protein, which ...
Leggi tutto

Construction of new EMA building in Amsterdam on track

May 29, 2018 - The laying of the foundation stone for the European Medicines Agency’s (EMA) new building in the Zuidas area of Amsterdam was marked with a ceremony on Monday, 28 May 2018. Speaking to representatives from the Dutch governmentExternal link icon, the ...
Leggi tutto

Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or RadiotherapyA Systematic Review and Meta-analysis

Studies investigating the association of cigarette smoking with prostate cancer incidence and outcomes have revealed controversial results. To systematically review and analyze the association of smoking status with biochemical recurrence, metastasis, and cancer-specific ...
Leggi tutto

Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial

Incorporating tobacco treatment within lung cancer screening programs has the potential to influence cessation in high-risk smokers. We aimed to better understand the characteristics of smokers within a screening cohort, correlate those variables with downstream outcomes, ...
Leggi tutto

Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay

The 21-gene recurrence score (RS) (Oncotype DX®; Genomic Health, Redwood City, CA) partitions hormone receptor positive, node negative breast cancers into three risk groups for recurrence. The Anne Arundel Medical Center (AAMC) model has previously been shown to accurately ...
Leggi tutto

Hormone replacement therapy for women previously treated for endometrial cancer

Endometrial cancer is the sixth most common cancer in women worldwide and most commonly occurs after the menopause (75%) (globocan.iarc.fr). About 319,000 new cases were diagnosed worldwide in 2012. Endometrial cancer is commonly considered as a potentially 'curable cancer,' ...
Leggi tutto

Dal Soroptimist International Club Genova a favore delle ragazze STEM

Il Premio, del valore di 2.000 Euro, sarà attribuito ad una Tesi di Laurea Magistrale in campo Emato-Oncologico, discussa da una studentessa dell’Università degli Studi di Genova negli anni accademici 2016-17 o 2017-18, in una delle seguenti discipline: ...
Leggi tutto

Premio ‘Giovanni Gardin’ 2018

La Sezione Regionale AIOM Liguria ha istituito il Premio ‘Giovanni Gardin’ 2018, riservato a Giovani Oncologi di età non superiore ai 40 anni (nell’anno solare in corso), quale riconoscimento per i migliori progetti su argomenti a cui il dottor Giovanni ...
Leggi tutto